Oragenics, Inc. Gains 48.57%
Mon, Aug 12, 2024 at 07:16 PM
Oragenics, Inc. (OGEN:NYSEMKT) soared at $2.08, representing a gain of 48.6%. On Mon, Aug 12, 2024, OGEN:NYSEMKT hit a New 2-Week High of $2.08. The stock got featured on our News Catalysts scanner on Mon, Aug 12, 2024 at 03:29 PM in the 'BIOTECH' category. From Mon, Jul 29, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Mon, May 20, 2024 at $3.43 with a volume of 1M+.
About Oragenics, Inc. (OGEN:NYSEMKT)
Oragenics Inc is a biopharmaceutical company which engages in the discovery, development and commercialization of technologies associated with oral health, broad spectrum antibiotics and other general health benefits.
Top 10 Gainers:
- Greenlane Holdings, Inc. (GNLN:NASDAQ), 360%
- PS International Group Ltd. (PSIG:NASDAQ), 127.72%
- Kubient Inc. (KBNT:NASDAQ), 100%
- Revance Therapeutics, Inc. (RVNC:NASDAQ), 86.97%
- Interactive Strength Inc. (TRNR:NASDAQ), 79.05%
- Unico American Corporation (UNAM:NASDAQ), 75%
- Conifer Holdings, Inc. (CNFR:NASDAQ), 53.85%
- Oragenics, Inc. (OGEN:NYSEMKT), 48.57%
- WaveDancer Inc. (WAVD:NASDAQ), 45.41%
- 60 Degrees Pharmaceuticals Inc. (SXTP:NASDAQ), 44.69%